295 related articles for article (PubMed ID: 33275692)
1. Management of toxicities associated with targeted therapies for acute myeloid leukemia: when to push through and when to stop.
Wang ES; Baron J
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):57-66. PubMed ID: 33275692
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapies in Acute Myeloid Leukemia: a focus on FLT-3 inhibitors and ABT199.
Naqvi K; Konopleva M; Ravandi F
Expert Rev Hematol; 2017 Oct; 10(10):863-874. PubMed ID: 28799432
[TBL] [Abstract][Full Text] [Related]
3. Acute Myeloid Leukemia: from Mutation Profiling to Treatment Decisions.
DiNardo C; Lachowiez C
Curr Hematol Malig Rep; 2019 Oct; 14(5):386-394. PubMed ID: 31350639
[TBL] [Abstract][Full Text] [Related]
4. Acute Myeloid Leukemia: Update on Upfront Therapy in Elderly Patients.
Keiffer G; Palmisiano N
Curr Oncol Rep; 2019 Jun; 21(8):71. PubMed ID: 31250135
[TBL] [Abstract][Full Text] [Related]
5. The rocky road to personalized medicine in acute myeloid leukaemia.
Brinda B; Khan I; Parkin B; Konig H
J Cell Mol Med; 2018 Mar; 22(3):1411-1427. PubMed ID: 29327808
[TBL] [Abstract][Full Text] [Related]
6. Clinical potential of introducing next-generation sequencing in patients at relapse of acute myeloid leukemia.
Flach J; Shumilov E; Wiedemann G; Porret N; Shakhanova I; Bürki S; Legros M; Joncourt R; Pabst T; Bacher U
Hematol Oncol; 2020 Oct; 38(4):425-431. PubMed ID: 32306411
[TBL] [Abstract][Full Text] [Related]
7. New drug approvals in acute myeloid leukemia: an unprecedented paradigm shift.
Kopmar NE; Estey EH
Clin Adv Hematol Oncol; 2019 Oct; 17(10):569-575. PubMed ID: 31730583
[TBL] [Abstract][Full Text] [Related]
8. Molecular-Targeted Therapy of Pediatric Acute Myeloid Leukemia.
Obszański P; Kozłowska A; Wańcowiat J; Twardowska J; Lejman M; Zawitkowska J
Molecules; 2022 Jun; 27(12):. PubMed ID: 35745032
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase inhibitors for acute myeloid leukemia: A step toward disease control?
Megías-Vericat JE; Ballesta-López O; Barragán E; Martínez-Cuadrón D; Montesinos P
Blood Rev; 2020 Nov; 44():100675. PubMed ID: 32147087
[TBL] [Abstract][Full Text] [Related]
10. Molecularly targeted therapy in acute myeloid leukemia.
Gill H; Leung AY; Kwong YL
Future Oncol; 2016 Mar; 12(6):827-38. PubMed ID: 26828965
[TBL] [Abstract][Full Text] [Related]
11. Updates on DNA methylation modifiers in acute myeloid leukemia.
Contieri B; Duarte BKL; Lazarini M
Ann Hematol; 2020 Apr; 99(4):693-701. PubMed ID: 32025842
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia: advancing clinical trials and promising therapeutics.
Daver N; Cortes J; Kantarjian H; Ravandi F
Expert Rev Hematol; 2016 May; 9(5):433-45. PubMed ID: 26910051
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia: current progress and future directions.
Kantarjian H; Kadia T; DiNardo C; Daver N; Borthakur G; Jabbour E; Garcia-Manero G; Konopleva M; Ravandi F
Blood Cancer J; 2021 Feb; 11(2):41. PubMed ID: 33619261
[TBL] [Abstract][Full Text] [Related]
14. An expert overview of emerging therapies for acute myeloid leukemia: novel small molecules targeting apoptosis, p53, transcriptional regulation and metabolism.
Saxena K; Konopleva M
Expert Opin Investig Drugs; 2020 Sep; 29(9):973-988. PubMed ID: 32746655
[TBL] [Abstract][Full Text] [Related]
15. Challenges in Converting Acute Myeloid Leukemia (AML) Genomics Into AML Clinical Trials.
Caywood EH; Kolb EA
J Clin Oncol; 2015 Dec; 33(36):4238-9. PubMed ID: 26573081
[No Abstract] [Full Text] [Related]
16. CDK9 inhibitors in acute myeloid leukemia.
Boffo S; Damato A; Alfano L; Giordano A
J Exp Clin Cancer Res; 2018 Feb; 37(1):36. PubMed ID: 29471852
[TBL] [Abstract][Full Text] [Related]
17. Novel Treatment Paradigms in Acute Myeloid Leukemia.
Khanal N; Upadhyay Banskota S; Bhatt VR
Clin Pharmacol Ther; 2020 Sep; 108(3):506-514. PubMed ID: 32572947
[TBL] [Abstract][Full Text] [Related]
18. Novel therapies for AML: a round-up for clinicians.
Swaminathan M; Wang ES
Expert Rev Clin Pharmacol; 2020 Dec; 13(12):1389-1400. PubMed ID: 33412978
[No Abstract] [Full Text] [Related]
19. Targeting LSD1 for acute myeloid leukemia (AML) treatment.
Zhang S; Liu M; Yao Y; Yu B; Liu H
Pharmacol Res; 2021 Feb; 164():105335. PubMed ID: 33285227
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis targeted therapies in acute myeloid leukemia: an update.
Ball S; Borthakur G
Expert Rev Hematol; 2020 Dec; 13(12):1373-1386. PubMed ID: 33205684
[No Abstract] [Full Text] [Related]
[Next] [New Search]